Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $23.1750, but opened at $20.49. Hikma Pharmaceuticals shares last traded at $20.49, with a volume of 100 shares.
Hikma Pharmaceuticals Stock Down 11.6%
The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.72 and a current ratio of 1.24. The firm’s fifty day moving average is $23.37 and its 200 day moving average is $25.62.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Most active stocks: Dollar volume vs share volume
- Amgen Stock: New All-Time Highs Ahead After Earnings Beat
- What is a Bond Market Holiday? How to Invest and Trade
- Netflix Stock Split Explained: What It Means for Investors
- Trading Stocks: RSI and Why it’s Useful
- SoundHound Beat Earnings & Dropped—Here’s What Wall Street Missed
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
